P51811 (XK_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 106.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Membrane transport protein XK Alternative name(s): Kell complex 37 kDa component Kx antigen XK-related protein 1 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 444 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | May be involved in sodium-dependent transport of neutral amino acids or oligopeptides. |
| Subunit structure | Heterodimer with Kell; disulfide-linked. Ref.7 |
| Subcellular location | Membrane; Multi-pass membrane protein Potential. |
| Tissue specificity | High levels in skeletal muscle, heart, brain, and pancreas; low levels in placenta, lung, liver, and kidney. |
| Post-translational modification | Not glycosylated. Ref.6 |
| Polymorphism | XK is responsible for the Kx blood group system. |
| Involvement in disease | McLeod syndrome (MLS) [MIM:300842]: A multisystem disorder characterized by the absence of red blood cell Kx antigen, weak espression of Kell red blood cell antigens, acanthocytosis, and compensated hemolysis. Most carriers of this McLeod blood group phenotype have acanthocytosis and elevated serum creatine kinase levels and are prone to develop a severe neurologic disorder resembling Huntington disease. Additional symptoms include generalized seizures, neuromuscular symptoms leading to weakness and atrophy, and cardiomyopathy mainly manifesting with atrial fibrillation, malignant arrythmias, and dilated cardiomyopathy. |
| Sequence similarities | Belongs to the XK family. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Amino-acid transport Transport |
| Cellular component | Membrane |
| Disease | Disease mutation |
| Domain | Transmembrane Transmembrane helix |
| Molecular function | Blood group antigen |
| PTM | Disulfide bond |
| Technical term | Complete proteome Direct protein sequencing Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | amino acid transport Inferred from electronic annotation. Source: UniProtKB-KW |
| Cellular_component | integral to membrane Traceable author statement PubMed 9647734. Source: HGNC |
| Molecular_function | transporter activity Traceable author statement Ref.1. Source: ProtInc |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 444 | 444 | Membrane transport protein XK | PRO_0000190767 | |||||
Regions | |||||||||
| Topological domain | 1 – 2 | 2 | Cytoplasmic Potential | ||||||
| Transmembrane | 3 – 23 | 21 | Helical; Potential | ||||||
| Topological domain | 24 – 37 | 14 | Extracellular Potential | ||||||
| Transmembrane | 38 – 58 | 21 | Helical; Potential | ||||||
| Topological domain | 59 – 68 | 10 | Cytoplasmic Potential | ||||||
| Transmembrane | 69 – 89 | 21 | Helical; Potential | ||||||
| Topological domain | 90 – 140 | 51 | Extracellular Potential | ||||||
| Transmembrane | 141 – 161 | 21 | Helical; Potential | ||||||
| Topological domain | 162 – 171 | 10 | Cytoplasmic Potential | ||||||
| Transmembrane | 172 – 192 | 21 | Helical; Potential | ||||||
| Topological domain | 193 – 208 | 16 | Extracellular Potential | ||||||
| Transmembrane | 209 – 229 | 21 | Helical; Potential | ||||||
| Topological domain | 230 – 235 | 6 | Cytoplasmic Potential | ||||||
| Transmembrane | 236 – 256 | 21 | Helical; Potential | ||||||
| Topological domain | 257 – 277 | 21 | Extracellular Potential | ||||||
| Transmembrane | 278 – 298 | 21 | Helical; Potential | ||||||
| Topological domain | 299 – 317 | 19 | Cytoplasmic Potential | ||||||
| Transmembrane | 318 – 338 | 21 | Helical; Potential | ||||||
| Topological domain | 339 – 349 | 11 | Extracellular Potential | ||||||
| Transmembrane | 350 – 370 | 21 | Helical; Potential | ||||||
| Topological domain | 371 – 444 | 74 | Cytoplasmic Potential | ||||||
Amino acid modifications | |||||||||
| Disulfide bond | 347 | Interchain (with C-72 in Kell) Ref.7 | |||||||
Natural variations | |||||||||
| Natural variant | 222 | 1 | R → G in MLS. Ref.9 | VAR_013817 | |||||
| Natural variant | 294 | 1 | C → R in MLS. Ref.8 Corresponds to variant rs28933690 [ dbSNP | Ensembl ]. | VAR_013818 | |||||
| Natural variant | 327 | 1 | E → K in MLS; atypical without hematologic, neuromuscular, or cerebral involvement; protein seems functional. Ref.10 | VAR_023581 | |||||
Experimental info | |||||||||
| Mutagenesis | 347 | 1 | C → S: Loss of Kell-XK complex. Ref.7 | ||||||
| Sequence conflict | 248 | 1 | F → L Ref.3 | ||||||
| Sequence conflict | 248 | 1 | F → L Ref.5 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein." Ho M., Chelly J., Carter N., Danek A., Crocker P., Monaco A.P. Cell 77:869-880(1994) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [2] | Ho M. Submitted (MAY-1999) to the EMBL/GenBank/DDBJ databases Cited for: SEQUENCE REVISION TO 204-205. |
| [3] | "A superfamily of XK-related genes (XRG) widely expressed in vertebrates and invertebrates." Huang C.-H., Chen Y. Submitted (JAN-2004) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [4] | SeattleSNPs variation discovery resource Submitted (MAY-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Testis. |
| [6] | "Purification and partial characterization of the erythrocyte Kx protein deficient in McLeod patients." Khamlichi S., Bailly P., Blanchard D., Goossens D., Cartron J.-P., Bertrand O. Eur. J. Biochem. 228:931-934(1995) [PubMed] [Europe PMC] [Abstract] Cited for: PROTEIN SEQUENCE OF 1-22, LACK OF GLYCOSYLATION. |
| [7] | "Association of XK and Kell blood group proteins." Russo D., Redman C., Lee S. J. Biol. Chem. 273:13950-13956(1998) [PubMed] [Europe PMC] [Abstract] Cited for: SUBUNIT, DISULFIDE BOND, MUTAGENESIS OF CYS-347. |
| [8] | "McLeod neuroacanthocytosis: genotype and phenotype." Danek A., Rubio J.P., Rampoldi L., Ho M., Dobson-Stone C., Tison F., Symmans W.A., Oechsner M., Kalckreuth W., Watt J.M., Corbett A.J., Hamdalla H.H., Marshall A.G., Sutton I., Dotti M.T., Malandrini A., Walker R.H., Daniels G., Monaco A.P. Ann. Neurol. 50:755-764(2001) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT MLS ARG-294. |
| [9] | "Point mutations causing the McLeod phenotype." Russo D.C., Lee S., Reid M.E., Redman C.M. Transfusion 42:287-293(2002) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT MLS GLY-222. |
| [10] | "McLeod phenotype associated with a XK missense mutation without hematologic, neuromuscular, or cerebral involvement." Jung H.H., Hergersberg M., Vogt M., Pahnke J., Treyer V., Rothlisberger B., Kollias S.S., Russo D., Frey B.M. Transfusion 43:928-938(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT MLS LYS-327. |
| + | Additional computationally mapped references. |
Web resources
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | Z32684 mRNA. Translation: CAA83632.2. AY534238 mRNA. Translation: AAT07087.1. DQ062746 Genomic DNA. Translation: AAY43132.1. BC036019 mRNA. Translation: AAH36019.1. |
| IPI | IPI00020896. |
| PIR | I39294. |
| RefSeq | NP_066569.1. NM_021083.2. |
| UniGene | Hs.78919. |
3D structure databases | |
| ProteinModelPortal | P51811. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | P51811. 1 interaction. |
| STRING | 9606.ENSP00000367879. |
Protein family/group databases | |
| TCDB | 9.B.5.1.1. KX blood-group antigen (KXA) family. |
PTM databases | |
| PhosphoSite | P51811. |
Polymorphism databases | |
| DMDM | 85700269. |
Proteomic databases | |
| PaxDb | P51811. |
| PRIDE | P51811. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000378616; ENSP00000367879; ENSG00000047597. ENST00000601300; ENSP00000469825; ENSG00000269380. |
| GeneID | 7504. |
| KEGG | hsa:7504. |
| UCSC | uc004ddq.3. human. |
Organism-specific databases | |
| CTD | 7504. |
| GeneCards | GC0XP037545. |
| HGNC | HGNC:12811. XK. |
| HPA | HPA019036. |
| MIM | 300842. phenotype. 314850. gene. |
| neXtProt | NX_P51811. |
| Orphanet | 59306. McLeod neuroacanthocytosis syndrome. |
| PharmGKB | PA37410. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | NOG149424. |
| HOGENOM | HOG000118070. |
| HOVERGEN | HBG055838. |
| InParanoid | P51811. |
| OMA | TYRSAGD. |
| OrthoDB | EOG40ZQXS. |
| PhylomeDB | P51811. |
Gene expression databases | |
| ArrayExpress | P51811. |
| Bgee | P51811. |
| CleanEx | HS_XK. |
| Genevestigator | P51811. |
| GermOnline | ENSG00000047597. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR018629. Transport_prot_XK. [Graphical view] |
| Pfam | PF09815. XK-related. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| GenomeRNAi | 7504. |
| NextBio | 29381. |
| SOURCE | Search... |
Entry information
| Entry name | XK_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P51811 Secondary accession number(s): Q4TTN6, Q8IUK6, Q9UC77 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Blood group antigen proteins Nomenclature of blood group antigens and list of entries |
| Human chromosome X Human chromosome X: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
